PATTON JOHN STUART 4
4 · HALOZYME THERAPEUTICS INC · Filed Oct 2, 2007
Insider Transaction Report
Form 4
PATTON JOHN STUART
Director
Transactions
- Sale
Common Stock
2007-10-02$8.79/sh−500$4,395→ 59,500 total - Sale
Common Stock
2007-10-02$8.86/sh−2,075$18,385→ 55,456 total - Sale
Common Stock
2007-10-02$8.87/sh−561$4,976→ 54,895 total - Sale
Common Stock
2007-10-02$8.91/sh−1,132$10,086→ 49,668 total - Sale
Common Stock
2007-10-02$8.82/sh−164$1,446→ 58,736 total - Sale
Common Stock
2007-10-02$8.89/sh−2,295$20,403→ 51,700 total - Sale
Common Stock
2007-10-02$8.94/sh−800$7,152→ 48,200 total - Sale
Common Stock
2007-10-02$8.96/sh−100$896→ 47,500 total - Sale
Common Stock
2007-10-02$8.98/sh−1,400$12,572→ 45,900 total - Sale
Common Stock
2007-10-02$8.92/sh−368$3,283→ 49,300 total - Sale
Common Stock
2007-10-02$8.99/sh−381$3,425→ 45,519 total - Sale
Common Stock
2007-10-02$8.88/sh−900$7,992→ 53,995 total - Sale
Common Stock
2007-10-02$8.85/sh−405$3,584→ 57,531 total - Sale
Common Stock
2007-10-02$8.80/sh−300$2,640→ 59,200 total - Sale
Common Stock
2007-10-02$8.95/sh−600$5,370→ 47,600 total - Sale
Common Stock
2007-10-02$9.00/sh−519$4,671→ 45,000 total - Sale
Common Stock
2007-10-02$8.97/sh−200$1,794→ 47,300 total
Footnotes (1)
- [F1]Shares purchased and sold, as applicable, pursuant to 10b5-1 Plan.